Global Hemostasis Trials Review Market Growth, Trend & Forecast to 2015 Radiant Insights, Inc
Summary GlobalData's clinical trial report, “Hemostasis Global Clinical Trials Review, H1, 2015"" provides an overview of Hemostasis clinical trials scenario. This report provides top line data relating to the clinical trials on Hemostasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage. Browse Full Report With TOC @ http://www.radiantinsights.com/research/hemostasis-global-clinical-trials-review-h1-2015 Scope The report provides a snapshot of the global clinical trials landscape Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment The Report provides enrollment trends for the past five years Report provides latest news for the past three months Reasons to buy Assists in formulating key business strategies with regards to investment Helps in identifying prominent locations for conducting clinical trials which saves time and cost Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities Supports understanding of trials count and enrollment trends by country in global therapeutics market Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials Facilitates clinical trial assessment of the indication on a global, regional and country level
Summary
GlobalData's clinical trial report, “Hemostasis Global Clinical Trials Review, H1, 2015"" provides an overview of Hemostasis clinical trials scenario. This report provides top line data relating to the clinical trials on Hemostasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
Browse Full Report With TOC @ http://www.radiantinsights.com/research/hemostasis-global-clinical-trials-review-h1-2015
Scope
The report provides a snapshot of the global clinical trials landscape
Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
The Report provides enrollment trends for the past five years
Report provides latest news for the past three months
Reasons to buy
Assists in formulating key business strategies with regards to investment
Helps in identifying prominent locations for conducting clinical trials which saves time and cost
Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
Supports understanding of trials count and enrollment trends by country in global therapeutics market
Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
Facilitates clinical trial assessment of the indication on a global, regional and country level
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Global</strong> <strong>Hemostasis</strong> <strong>Trials</strong> <strong>Review</strong> <strong>Market</strong> <strong>Growth</strong>, <strong>Trend</strong> &<br />
<strong>Forecast</strong> <strong>to</strong> <strong>2015</strong>: <strong>Radiant</strong> <strong>Insights</strong>, <strong>Inc</strong><br />
Summary<br />
<strong>Global</strong>Data's clinical trial report, “<strong>Hemostasis</strong> <strong>Global</strong> Clinical <strong>Trials</strong> <strong>Review</strong>, H1, <strong>2015</strong>"" provides an<br />
overview of <strong>Hemostasis</strong> clinical trials scenario. This report provides <strong>to</strong>p line data relating <strong>to</strong> the clinical<br />
trials on <strong>Hemostasis</strong>. Report includes an overview of trial numbers and their average enrollment in <strong>to</strong>p<br />
countries conducted across the globe. The report offers coverage of disease clinical trials by region,<br />
country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent<br />
drugs for in-progress trials (based on number of ongoing trials). <strong>Global</strong> Data Clinical Trial Reports are<br />
generated using <strong>Global</strong> Data’s proprietary database Pharma eTrack Clinical trials database. Clinical trials<br />
are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe.<br />
Clinical trials database undergoes periodic update by dynamic process.<br />
The report enhances the decision making capabilities and helps <strong>to</strong> create an effective counter strategies <strong>to</strong><br />
gain competitive advantage.<br />
Browse Full Report With TOC @ http://www.radiantinsights.com/research/hemostasis-globalclinical-trials-review-h1-<strong>2015</strong><br />
Scope<br />
The report provides a snapshot of the global clinical trials landscape<br />
Report provides <strong>to</strong>p level data related <strong>to</strong> the clinical trials by Region, Country (G7 & E7), Trial Status,<br />
Trial Phase, Sponsor Type and End point status<br />
The report reviews <strong>to</strong>p companies involved and enlists all trials (Trial title, Phase, and Status) pertaining<br />
<strong>to</strong> the company<br />
The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason<br />
for unaccomplishment<br />
The Report provides enrollment trends for the past five years<br />
Report provides latest news for the past three months<br />
Reasons <strong>to</strong> buy<br />
Assists in formulating key business strategies with regards <strong>to</strong> investment<br />
Helps in identifying prominent locations for conducting clinical trials which saves time and cost
Provides <strong>to</strong>p level analysis of <strong>Global</strong> Clinical <strong>Trials</strong> <strong>Market</strong> which helps in identifying key business<br />
opportunities<br />
Supports understanding of trials count and enrollment trends by country in global therapeutics market<br />
Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed<br />
and uncompleted (terminated, suspended or withdrawn) trials<br />
Facilitates clinical trial assessment of the indication on a global, regional and country level<br />
Table of Contents<br />
Table of Contents 2<br />
List of Tables 4<br />
List of Figures 5<br />
Introduction 6<br />
<strong>Hemostasis</strong> 6<br />
Report Guidance 6<br />
Clinical <strong>Trials</strong> by Region 7<br />
Browse Full Report With TOC @ http://www.radiantinsights.com/research/hemostasis-globalclinical-trials-review-h1-<strong>2015</strong><br />
Clinical <strong>Trials</strong> and Average Enrollment by Country 8<br />
Top Five Countries Contributing <strong>to</strong> Clinical <strong>Trials</strong> in Asia-Pacific 10<br />
Top Five Countries Contributing <strong>to</strong> Clinical <strong>Trials</strong> in Europe 11<br />
Top Countries Contributing <strong>to</strong> Clinical <strong>Trials</strong> in North America 12<br />
Top Countries Contributing <strong>to</strong> Clinical <strong>Trials</strong> in Middle East and Africa 13<br />
Top Countries Contributing <strong>to</strong> Clinical <strong>Trials</strong> in Central and South America 14<br />
Clinical <strong>Trials</strong> by G7 Countries: Proportion of <strong>Hemostasis</strong> <strong>to</strong> Hema<strong>to</strong>logical Disorders Clinical <strong>Trials</strong> 15<br />
Clinical <strong>Trials</strong> by Phase in G7 Countries 16<br />
Clinical <strong>Trials</strong> in G7 Countries by Trial Status 17<br />
Clinical <strong>Trials</strong> by E7 Countries: Proportion of <strong>Hemostasis</strong> <strong>to</strong> Hema<strong>to</strong>logical Disorders Clinical <strong>Trials</strong> 18
Clinical <strong>Trials</strong> by Phase in E7 Countries 19<br />
Clinical <strong>Trials</strong> in E7 Countries by Trial Status 20<br />
Clinical <strong>Trials</strong> by Phase 21<br />
In Progress <strong>Trials</strong> by Phase 22<br />
Clinical <strong>Trials</strong> by Trial Status 23<br />
Clinical <strong>Trials</strong> by End Point Status 24<br />
Unaccomplished <strong>Trials</strong> of <strong>Hemostasis</strong> 25<br />
Subjects Recruited Over a Period of Time 27<br />
Clinical <strong>Trials</strong> by Sponsor Type 28<br />
Prominent Sponsors 29<br />
Top Companies Participating in <strong>Hemostasis</strong> Therapeutics Clinical <strong>Trials</strong> 30<br />
Browse Full Report With TOC @ http://www.radiantinsights.com/research/hemostasis-globalclinical-trials-review-h1-<strong>2015</strong><br />
Prominent Drugs 31<br />
Clinical Trial Profiles 32<br />
Clinical Trial Overview of Top Companies 32<br />
Baxter International <strong>Inc</strong>. 32<br />
Clinical Trial Overview of Baxter International <strong>Inc</strong>. 32<br />
Takeda Pharmaceutical Company Limited 33<br />
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 33<br />
Johnson & Johnson 34<br />
Clinical Trial Overview of Johnson & Johnson 34<br />
Novo A/S 35<br />
Clinical Trial Overview of Novo A/S 35<br />
Grifols, S.A. 36<br />
Clinical Trial Overview of Grifols, S.A. 36
ZymoGenetics, <strong>Inc</strong>. (Inactive) 37<br />
Clinical Trial Overview of ZymoGenetics, <strong>Inc</strong>. (Inactive) 37<br />
The Medicines Company 38<br />
Clinical Trial Overview of The Medicines Company 38<br />
LAL Clinica Pesquisa e Desenvolvimen<strong>to</strong> Ltda 39<br />
Clinical Trial Overview of LAL Clinica Pesquisa e Desenvolvimen<strong>to</strong> Ltda 39<br />
Teva Pharmaceutical Industries Limited 40<br />
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 40<br />
Omrix Biopharmaceuticals, <strong>Inc</strong>. (Inactive) 41<br />
Clinical Trial Overview of Omrix Biopharmaceuticals, <strong>Inc</strong>. (Inactive) 41<br />
Clinical Trial Overview of Top Institutes / Government 42<br />
Radboud University 42<br />
Browse Full Report With TOC @ http://www.radiantinsights.com/research/hemostasis-globalclinical-trials-review-h1-<strong>2015</strong><br />
Clinical Trial Overview of Radboud University 42<br />
Academic Medical Center 43<br />
Clinical Trial Overview of Academic Medical Center 43<br />
Austin Health 44<br />
Clinical Trial Overview of Austin Health 44<br />
Azienda Ospedaliera Universitaria Senese 45<br />
Clinical Trial Overview of Azienda Ospedaliera Universitaria Senese 45<br />
Azienda Unita Sanitaria Locale Lecce 46<br />
Clinical Trial Overview of Azienda Unita Sanitaria Locale Lecce 46<br />
Bassett Healthcare 47<br />
Clinical Trial Overview of Bassett Healthcare 47<br />
Capital District Health Authority, Canada 48
Clinical Trial Overview of Capital District Health Authority, Canada 48<br />
Eidgenossische Technische Hochschule Zurich 49<br />
Clinical Trial Overview of Eidgenossische Technische Hochschule Zurich 49<br />
Esbjerg Dentallabora<strong>to</strong>rium Aps 50<br />
Clinical Trial Overview of Esbjerg Dentallabora<strong>to</strong>rium Aps 50<br />
Fundacio Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 51<br />
Clinical Trial Overview of Fundacio Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 51<br />
Five Key Clinical Profiles 52<br />
Appendix 90<br />
Abbreviations 90<br />
Browse Full Report With TOC @ http://www.radiantinsights.com/research/hemostasis-globalclinical-trials-review-h1-<strong>2015</strong><br />
Definitions 90<br />
Research Methodology 91<br />
Secondary Research 91<br />
About <strong>Global</strong>Data 92<br />
Contact Us 92<br />
Disclaimer 92<br />
Source 93<br />
List of Tables<br />
<strong>Hemostasis</strong> Therapeutics, <strong>Global</strong>, Clinical <strong>Trials</strong> by Region, <strong>2015</strong>* 7<br />
<strong>Hemostasis</strong> Therapeutics, <strong>Global</strong>, Clinical <strong>Trials</strong> and Average Enrollment by Top Countries, <strong>2015</strong>* 8<br />
<strong>Hemostasis</strong> Therapeutics, <strong>Global</strong>, Clinical <strong>Trials</strong> In Progress by Top Countries, <strong>2015</strong>* 9<br />
<strong>Hemostasis</strong> Therapeutics Clinical <strong>Trials</strong>, Asia-Pacific, Top Five Countries, <strong>2015</strong>* 10<br />
<strong>Hemostasis</strong> Therapeutics Clinical <strong>Trials</strong>, Europe, Top Five Countries, <strong>2015</strong>* 11
<strong>Hemostasis</strong> Therapeutics Clinical <strong>Trials</strong>, North America, Top Countries, <strong>2015</strong>* 12<br />
<strong>Hemostasis</strong> Therapeutics Clinical <strong>Trials</strong>, Middle East and Africa, Top Countries, <strong>2015</strong>* 13<br />
<strong>Hemostasis</strong> Therapeutics Clinical <strong>Trials</strong>, Central and South America, Top Countries, <strong>2015</strong>* 14<br />
Proportion of <strong>Hemostasis</strong> <strong>to</strong> Hema<strong>to</strong>logical Disorders Clinical <strong>Trials</strong>, G7 Countries (%), <strong>2015</strong>* 15<br />
<strong>Hemostasis</strong> Therapeutics, G7 Countries, Clinical <strong>Trials</strong> by Phase, <strong>2015</strong>* 16<br />
<strong>Hemostasis</strong> Therapeutics, G7 Countries, Clinical <strong>Trials</strong> by Trial Status, <strong>2015</strong>* 17<br />
Proportion of <strong>Hemostasis</strong> <strong>to</strong> Hema<strong>to</strong>logical Disorders Clinical <strong>Trials</strong>, E7 Countries (%), <strong>2015</strong>* 18<br />
<strong>Hemostasis</strong> Therapeutics, E7 Countries, Clinical <strong>Trials</strong> by Phase, <strong>2015</strong>* 19<br />
<strong>Hemostasis</strong> Therapeutics, E7 Countries, Clinical <strong>Trials</strong> by Trial Status, <strong>2015</strong>* 20<br />
<strong>Hemostasis</strong> Therapeutics, <strong>Global</strong>, Clinical <strong>Trials</strong> by Phase, <strong>2015</strong>* 21<br />
Browse Full Report With TOC @ http://www.radiantinsights.com/research/hemostasis-globalclinical-trials-review-h1-<strong>2015</strong><br />
<strong>Hemostasis</strong> Therapeutics, <strong>Global</strong>, Clinical <strong>Trials</strong> In Progress by Phase <strong>2015</strong>* 22<br />
<strong>Hemostasis</strong> Therapeutics, <strong>Global</strong>, Clinical <strong>Trials</strong> by Trial Status, <strong>2015</strong>* 23<br />
<strong>Hemostasis</strong> Therapeutics Clinical <strong>Trials</strong>, <strong>Global</strong>, by End Point Status, <strong>2015</strong>* 24<br />
<strong>Hemostasis</strong> Therapeutics, <strong>Global</strong>, Withdrawn Clinical <strong>Trials</strong>, <strong>2015</strong>* 25<br />
<strong>Hemostasis</strong> Therapeutics, <strong>Global</strong>, Terminated Clinical <strong>Trials</strong>, <strong>2015</strong>* 26<br />
<strong>Hemostasis</strong> Therapeutics Clinical <strong>Trials</strong>, <strong>Global</strong>, Average Enrollment Target <strong>Trend</strong>s, 2010-2014 27<br />
<strong>Hemostasis</strong> Therapeutics <strong>Market</strong>, <strong>Global</strong>, Clinical <strong>Trials</strong> by Sponsor Type, <strong>2015</strong>* 28<br />
<strong>Hemostasis</strong> Therapeutics Clinical <strong>Trials</strong>, <strong>Global</strong>, Key Sponsors, <strong>2015</strong>* 29<br />
<strong>Hemostasis</strong> Therapeutics Clinical <strong>Trials</strong>, <strong>Global</strong>, Top Companies by Phase, <strong>2015</strong>* 30<br />
<strong>Hemostasis</strong> Therapeutics Clinical <strong>Trials</strong>, <strong>Global</strong>, Ongoing Clinical <strong>Trials</strong> by Prominent Drugs, <strong>2015</strong>* 31<br />
<strong>Hemostasis</strong> Therapeutics Clinical <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, Clinical <strong>Trials</strong> by Baxter International <strong>Inc</strong>.,<br />
<strong>2015</strong>* 32<br />
<strong>Hemostasis</strong> Therapeutics Clinical <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, Clinical <strong>Trials</strong> by Takeda Pharmaceutical<br />
Company Limited, <strong>2015</strong>* 33<br />
<strong>Hemostasis</strong> Therapeutics Clinical <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, Clinical <strong>Trials</strong> by Johnson & Johnson, <strong>2015</strong>* 34
<strong>Hemostasis</strong> Therapeutics Clinical <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, Clinical <strong>Trials</strong> by Novo A/S, <strong>2015</strong>* 35<br />
<strong>Hemostasis</strong> Therapeutics Clinical <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, Clinical <strong>Trials</strong> by Grifols, S.A., <strong>2015</strong>* 36<br />
<strong>Hemostasis</strong> Therapeutics Clinical <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, Clinical <strong>Trials</strong> by ZymoGenetics, <strong>Inc</strong>. (Inactive),<br />
<strong>2015</strong>* 37<br />
<strong>Hemostasis</strong> Therapeutics Clinical <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, Clinical <strong>Trials</strong> by The Medicines Company,<br />
<strong>2015</strong>* 38<br />
<strong>Hemostasis</strong> Therapeutics Clinical <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, Clinical <strong>Trials</strong> by LAL Clinica Pesquisa e<br />
Desenvolvimen<strong>to</strong> Ltda, <strong>2015</strong>* 39<br />
<strong>Hemostasis</strong> Therapeutics Clinical <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, Clinical <strong>Trials</strong> by Teva Pharmaceutical<br />
Industries Limited, <strong>2015</strong>* 40<br />
<strong>Hemostasis</strong> Therapeutics Clinical <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, Clinical <strong>Trials</strong> by Omrix Biopharmaceuticals,<br />
<strong>Inc</strong>. (Inactive), <strong>2015</strong>* 41<br />
<strong>Hemostasis</strong> Therapeutics Clinical <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, Clinical <strong>Trials</strong> by Radboud University, <strong>2015</strong>* 42<br />
Browse Full Report With TOC @ http://www.radiantinsights.com/research/hemostasis-globalclinical-trials-review-h1-<strong>2015</strong><br />
<strong>Hemostasis</strong> Therapeutics Clinical <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, Clinical <strong>Trials</strong> by Academic Medical Center,<br />
<strong>2015</strong>* 43<br />
<strong>Hemostasis</strong> Therapeutics Clinical <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, Clinical <strong>Trials</strong> by Austin Health, <strong>2015</strong>* 44<br />
<strong>Hemostasis</strong> Therapeutics Clinical <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, Clinical <strong>Trials</strong> by Azienda Ospedaliera<br />
Universitaria Senese, <strong>2015</strong>* 45<br />
<strong>Hemostasis</strong> Therapeutics Clinical <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, Clinical <strong>Trials</strong> by Azienda Unita Sanitaria<br />
Locale Lecce, <strong>2015</strong>* 46<br />
<strong>Hemostasis</strong> Therapeutics Clinical <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, Clinical <strong>Trials</strong> by Bassett Healthcare, <strong>2015</strong>* 47<br />
<strong>Hemostasis</strong> Therapeutics Clinical <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, Clinical <strong>Trials</strong> by Capital District Health<br />
Authority, Canada, <strong>2015</strong>* 48<br />
<strong>Hemostasis</strong> Therapeutics Clinical <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, Clinical <strong>Trials</strong> by Eidgenossische Technische<br />
Hochschule Zurich, <strong>2015</strong>* 49<br />
<strong>Hemostasis</strong> Therapeutics Clinical <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, Clinical <strong>Trials</strong> by Esbjerg Dentallabora<strong>to</strong>rium<br />
Aps, <strong>2015</strong>* 50<br />
<strong>Hemostasis</strong> Therapeutics Clinical <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, Clinical <strong>Trials</strong> by Fundacio Institut de Recerca<br />
de l'Hospital de la Santa Creu i Sant Pau, <strong>2015</strong>* 51
List of Figures<br />
<strong>Hemostasis</strong> Therapeutics, <strong>Global</strong>, Clinical <strong>Trials</strong> by Region (%), <strong>2015</strong>* 7<br />
<strong>Hemostasis</strong> Therapeutics, <strong>Global</strong>, Clinical <strong>Trials</strong> and Average Enrollment by Top Countries, <strong>2015</strong>* 8<br />
<strong>Hemostasis</strong> Therapeutics, <strong>Global</strong>, Clinical <strong>Trials</strong> In Progress by Top Countries, <strong>2015</strong>* 9<br />
<strong>Hemostasis</strong> Therapeutics Clinical <strong>Trials</strong>, Asia-Pacific, Top Five Countries (%), <strong>2015</strong>* 10<br />
<strong>Hemostasis</strong> Therapeutics Clinical <strong>Trials</strong>, Europe, Top Five Countries (%), <strong>2015</strong>* 11<br />
<strong>Hemostasis</strong> Therapeutics Clinical <strong>Trials</strong>, North America, Top Countries (%), <strong>2015</strong>* 12<br />
<strong>Hemostasis</strong> Therapeutics Clinical <strong>Trials</strong>, Middle East and Africa, Top Countries (%), <strong>2015</strong>* 13<br />
Proportion of <strong>Hemostasis</strong> <strong>to</strong> Hema<strong>to</strong>logical Disorders Clinical <strong>Trials</strong>, G7 Countries (%), <strong>2015</strong>* 15<br />
<strong>Hemostasis</strong> Therapeutics, G7 Countries, Clinical <strong>Trials</strong> by Phase, <strong>2015</strong>* 16<br />
<strong>Hemostasis</strong> Therapeutics, G7 Countries, Clinical <strong>Trials</strong> by Trial Status, <strong>2015</strong>* 17<br />
Browse Full Report With TOC @ http://www.radiantinsights.com/research/hemostasis-globalclinical-trials-review-h1-<strong>2015</strong><br />
Proportion of <strong>Hemostasis</strong> <strong>to</strong> Hema<strong>to</strong>logical Disorders Clinical <strong>Trials</strong>, E7 Countries (%), <strong>2015</strong>* 18<br />
<strong>Hemostasis</strong> Therapeutics, E7 Countries, Clinical <strong>Trials</strong> by Phase, <strong>2015</strong>* 19<br />
<strong>Hemostasis</strong> Therapeutics, E7 Countries, Clinical <strong>Trials</strong> by Trial Status, <strong>2015</strong>* 20<br />
<strong>Hemostasis</strong> Therapeutics, <strong>Global</strong>, Clinical <strong>Trials</strong> by Phase (%), <strong>2015</strong>* 21<br />
<strong>Hemostasis</strong> Therapeutics, <strong>Global</strong>, Clinical <strong>Trials</strong> In Progress by Phase, <strong>2015</strong>* 22<br />
<strong>Hemostasis</strong> Therapeutics, <strong>Global</strong>, Clinical <strong>Trials</strong> by Trial Status, <strong>2015</strong>* 23<br />
<strong>Hemostasis</strong> Therapeutics Clinical <strong>Trials</strong>, <strong>Global</strong>, by End Point Status, <strong>2015</strong>* 24<br />
<strong>Hemostasis</strong> Therapeutics Clinical <strong>Trials</strong>, <strong>Global</strong>, Average Enrollment Target <strong>Trend</strong>s, 2010-2014 27<br />
<strong>Hemostasis</strong> Therapeutics <strong>Market</strong>, <strong>Global</strong>, Clinical <strong>Trials</strong> by Sponsor Type (%), <strong>2015</strong>* 28<br />
<strong>Hemostasis</strong> Therapeutics Clinical <strong>Trials</strong>, <strong>Global</strong>, Key Sponsors, <strong>2015</strong>* 29<br />
<strong>Hemostasis</strong> Therapeutics Clinical <strong>Trials</strong>, <strong>Global</strong>, Top Companies by Phase, <strong>2015</strong>* 30<br />
<strong>Hemostasis</strong> Therapeutics Clinical <strong>Trials</strong>, <strong>Global</strong>, Ongoing Clinical <strong>Trials</strong> by Prominent Drugs, <strong>2015</strong>* 31<br />
<strong>Global</strong>Data Methodology 91
About <strong>Radiant</strong> <strong>Insights</strong><br />
<strong>Radiant</strong> <strong>Insights</strong> is a platform for companies looking <strong>to</strong> meet their market research and business<br />
intelligence requirements. We assist and facilitate organizations and individuals procure market research<br />
reports, helping them in the decision making process. We have a comprehensive collection of reports,<br />
covering over 40 key industries and a host of micro markets. In addition <strong>to</strong> over extensive database of<br />
reports, our experienced research coordina<strong>to</strong>rs also offer a host of ancillary services such as, research<br />
partnerships/ tie-ups and cus<strong>to</strong>mized research solutions.<br />
For More Information, Visit <strong>Radiant</strong> <strong>Insights</strong><br />
Contact:<br />
Michelle Thoras<br />
Corporate Sales Specialist, USA<br />
<strong>Radiant</strong> <strong>Insights</strong>, <strong>Inc</strong><br />
Phone: 1-415-349-0054<br />
Toll Free: 1-888-202-9519<br />
Email: sales@radiantinsights.com<br />
Blog URL: http://www.radiantinsightsinc.blogspot.com
Change language